COVID-19 Clinical Trials

Find COVID-19 Clinical Trials Near You

Longitudinal Study of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Post-Acute Sequelae of COVID-19 (PASC)

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

This study will examine how common Long COVID is and how symptoms may persist over time in people who have previously had COVID-19. Researchers will collect information about participants' health and symptoms through questionnaires and may collect saliva and other non-invasive oral samples. The study will also examine biological factors in these samples that may be associated with persistent symptoms. The goal is to better understand why some people develop Long COVID and identify factors that may help predict who is more likely to experience persistent symptoms.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Age 18 to 75 years.

• Previous laboratory-confirmed SARS-CoV-2 infection.

• Willing and able to provide informed consent.

• Able to complete study questionnaires and study procedures.

Locations
United States
North Carolina
University of North Carolina
RECRUITING
Chapel Hill
Contact Information
Primary
Laura A Jacox, PhD, DMD, MS
ljacox@live.unc.edu
+1 847-702-0988
Backup
Jeannene L Matthews, MA, M.Ed., CCC-SLP
jeannene_matthews@med.unc.edu
+1 919-357-5999
Time Frame
Start Date: 2024-09-04
Estimated Completion Date: 2029-12-31
Participants
Target number of participants: 500
Treatments
COVID-19+
Adults who have previously had COVID-19 and may be experiencing ongoing symptoms or changes in their health following infection.
Sponsors
Leads: University of North Carolina, Chapel Hill
Collaborators: National Institute of Dental and Craniofacial Research (NIDCR)

This content was sourced from clinicaltrials.gov